Product Overview
Orteronel | T6051 | TargetMol Chemicals
CAS: 566939-85-3
Smiles: CNC(=O)c1ccc2cc(ccc2c1)[C@@]1(O)CCn2cncc12
Formula: C18H17N3O2
Pathway: Metabolism
Target: P450
Receptor: N/A
Bioactivity: Orteronel(TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.
Molecular Weight: 307, 353
